2019 annual financial data

Emergent BioSolutions 2019 Net margin

Emergent BioSolutions 2019 net margin with verified reported values.

Direct answer

Net margin was 4.93%.

Operating income was 114,100,000 USD and net income was 54,500,000 USD.
Operating cash flow was 188,000,000 USD.

Get free Emergent BioSolutions email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,106,000,000 USD
Operating income
114,100,000 USD
Net income
54,500,000 USD
Operating cash flow
188,000,000 USD